Global and United States Specialty Generics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Specialty Generics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Injectables
  • 1.2.3 Oral
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global Specialty Generics Market Share by Application: 2020 VS 2026
  • 1.3.2 Oncology
  • 1.3.3 Inflammatory Conditions
  • 1.3.4 Multiple Sclerosis
  • 1.3.5 Hepatitis C
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Specialty Generics Market Perspective (2015-2026)
• 2.2 Global Specialty Generics Growth Trends by Regions
  • 2.2.1 Specialty Generics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Specialty Generics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Specialty Generics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Specialty Generics Players by Market Size
  • 3.1.1 Global Top Specialty Generics Players by Revenue (2015-2020)
  • 3.1.2 Global Specialty Generics Revenue Market Share by Players (2015-2020)
• 3.2 Global Specialty Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Specialty Generics Revenue
• 3.4 Global Specialty Generics Market Concentration Ratio
  • 3.4.1 Global Specialty Generics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Specialty Generics Revenue in 2019
• 3.5 Key Players Specialty Generics Area Served
• 3.6 Key Players Specialty Generics Product Solution and Service
• 3.7 Date of Enter into Specialty Generics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Specialty Generics Breakdown Data by Type (2015-2026)

• 4.1 Global Specialty Generics Historic Market Size by Type (2015-2020)
• 4.2 Global Specialty Generics Forecasted Market Size by Type (2021-2026)

5 Specialty Generics Breakdown Data by Application (2015-2026)

• 5.1 Global Specialty Generics Historic Market Size by Application (2015-2020)
• 5.2 Global Specialty Generics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Specialty Generics Market Size (2015-2026)
• 6.2 North America Specialty Generics Market Size by Type (2015-2020)
• 6.3 North America Specialty Generics Market Size by Application (2015-2020)
• 6.4 North America Specialty Generics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Specialty Generics Market Size (2015-2026)
• 7.2 Europe Specialty Generics Market Size by Type (2015-2020)
• 7.3 Europe Specialty Generics Market Size by Application (2015-2020)
• 7.4 Europe Specialty Generics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Specialty Generics Market Size (2015-2026)
• 8.2 China Specialty Generics Market Size by Type (2015-2020)
• 8.3 China Specialty Generics Market Size by Application (2015-2020)
• 8.4 China Specialty Generics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Specialty Generics Market Size (2015-2026)
• 9.2 Japan Specialty Generics Market Size by Type (2015-2020)
• 9.3 Japan Specialty Generics Market Size by Application (2015-2020)
• 9.4 Japan Specialty Generics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Specialty Generics Market Size (2015-2026)
• 10.2 Southeast Asia Specialty Generics Market Size by Type (2015-2020)
• 10.3 Southeast Asia Specialty Generics Market Size by Application (2015-2020)
• 10.4 Southeast Asia Specialty Generics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Teva Pharmaceuticals USA, Inc.
  • 11.1.1 Teva Pharmaceuticals USA, Inc. Company Details
  • 11.1.2 Teva Pharmaceuticals USA, Inc. Business Overview
  • 11.1.3 Teva Pharmaceuticals USA, Inc. Specialty Generics Introduction
  • 11.1.4 Teva Pharmaceuticals USA, Inc. Revenue in Specialty Generics Business (2015-2020))
  • 11.1.5 Teva Pharmaceuticals USA, Inc. Recent Development
• 11.2 Mylan N.V.
  • 11.2.1 Mylan N.V. Company Details
  • 11.2.2 Mylan N.V. Business Overview
  • 11.2.3 Mylan N.V. Specialty Generics Introduction
  • 11.2.4 Mylan N.V. Revenue in Specialty Generics Business (2015-2020)
  • 11.2.5 Mylan N.V. Recent Development
• 11.3 Sandoz International GmbH
  • 11.3.1 Sandoz International GmbH Company Details
  • 11.3.2 Sandoz International GmbH Business Overview
  • 11.3.3 Sandoz International GmbH Specialty Generics Introduction
  • 11.3.4 Sandoz International GmbH Revenue in Specialty Generics Business (2015-2020)
  • 11.3.5 Sandoz International GmbH Recent Development
• 11.4 Akorn, Inc.
  • 11.4.1 Akorn, Inc. Company Details
  • 11.4.2 Akorn, Inc. Business Overview
  • 11.4.3 Akorn, Inc. Specialty Generics Introduction
  • 11.4.4 Akorn, Inc. Revenue in Specialty Generics Business (2015-2020)
  • 11.4.5 Akorn, Inc. Recent Development
• 11.5 Mallinckrodt
  • 11.5.1 Mallinckrodt Company Details
  • 11.5.2 Mallinckrodt Business Overview
  • 11.5.3 Mallinckrodt Specialty Generics Introduction
  • 11.5.4 Mallinckrodt Revenue in Specialty Generics Business (2015-2020)
  • 11.5.5 Mallinckrodt Recent Development
• 11.6 Valeant Pharmaceuticals International, Inc.
  • 11.6.1 Valeant Pharmaceuticals International, Inc. Company Details
  • 11.6.2 Valeant Pharmaceuticals International, Inc. Business Overview
  • 11.6.3 Valeant Pharmaceuticals International, Inc. Specialty Generics Introduction
  • 11.6.4 Valeant Pharmaceuticals International, Inc. Revenue in Specialty Generics Business (2015-2020)
  • 11.6.5 Valeant Pharmaceuticals International, Inc. Recent Development
• 11.7 Pfizer Inc.
  • 11.7.1 Pfizer Inc. Company Details
  • 11.7.2 Pfizer Inc. Business Overview
  • 11.7.3 Pfizer Inc. Specialty Generics Introduction
  • 11.7.4 Pfizer Inc. Revenue in Specialty Generics Business (2015-2020)
  • 11.7.5 Pfizer Inc. Recent Development
• 11.8 Endo Pharmaceuticals Inc.
  • 11.8.1 Endo Pharmaceuticals Inc. Company Details
  • 11.8.2 Endo Pharmaceuticals Inc. Business Overview
  • 11.8.3 Endo Pharmaceuticals Inc. Specialty Generics Introduction
  • 11.8.4 Endo Pharmaceuticals Inc. Revenue in Specialty Generics Business (2015-2020)
  • 11.8.5 Endo Pharmaceuticals Inc. Recent Development
• 11.9 Apotex Corp.
  • 11.9.1 Apotex Corp. Company Details
  • 11.9.2 Apotex Corp. Business Overview
  • 11.9.3 Apotex Corp. Specialty Generics Introduction
  • 11.9.4 Apotex Corp. Revenue in Specialty Generics Business (2015-2020)
  • 11.9.5 Apotex Corp. Recent Development
• 11.10 Sun Pharmaceutical Industries Ltd.
  • 11.10.1 Sun Pharmaceutical Industries Ltd. Company Details
  • 11.10.2 Sun Pharmaceutical Industries Ltd. Business Overview
  • 11.10.3 Sun Pharmaceutical Industries Ltd. Specialty Generics Introduction
  • 11.10.4 Sun Pharmaceutical Industries Ltd. Revenue in Specialty Generics Business (2015-2020)
  • 11.10.5 Sun Pharmaceutical Industries Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer